4
Changes in Ownership
ArriVent BioPharma, Inc. Filed Acc 0001104659-26-010473
Options or other derivatives
- Chief Financial Officer acquired 140,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kung Winston · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-02 | Grant or award : show line 1 in the form Stock Option (right to buy) | +140,000 | 140,000 | D |
Loading xslF345X05/tm265104-2_4seq1.xml…